Exozymes Inc.
EXOZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002010788
In the last 90 days, Exozymes Inc. insiders filed 1 open-market purchase and 0 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.05M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Exozymes Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 9 | +3 |
| Shares | 76.8K | 75.4K | −1.39K (−1.8%) |
| Value | $802.2K | $727.4K | −$74.8K (−9.3%) |
New holders (3)
Institutions that held Exozymes Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 18,144 | $174.2K | 0.00% |
| Raymond James Financial Inc | 2,000 | $19.8K | 0.00% |
| Morgan Stanley | 1,250 | $12.3K | 0.00% |
Sold out (0)
Institutions that held Exozymes Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
None.